drugset / Trial / NCT01540539
Intravenous/Subcutaneous FIH Study of REGN1154 in Healthy Volunteers
RandomizedParallel-groupTriple-blind
Summary
The purpose of this study is to study the safety and tolerability of intravenous (IV) and subcutaneous (SC) administration of REGN1154 in normal healthy subjects.
Timeline
- Start
- 2012-03
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | REGN1154 | Unknown | — | Intravenous |
Indications
No indication recorded.